tiprankstipranks
Advertisement

GB:CURE ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Buy
15Bullish
1Neutral
6Bearish
Oscillators
Sell
3Bullish
1Neutral
6Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Moving Averages Convergence Divergence (MACD) indicator is 0.91, suggesting VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is a Sell.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 20-Day exponential moving average is 24.13, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-Day exponential moving average is 23.03, making it a Buy.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Pivot Points

Aug 21, 2026, 03:21 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
24.83
24.85
25.81
25.83
26.79
26.80
27.76
Fibonacci
24.85
25.22
25.45
25.83
26.20
26.43
26.80

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Moving Averages

Aug 21, 2026, 03:21 PM
Period
Simple
Exponential
MA5
25.35Buy
25.80Buy
MA10
24.76Buy
24.96Buy
MA20
23.64Buy
24.13Buy
MA50
22.89Buy
23.03Buy
MA100
21.55Buy
22.26Buy
MA200
21.78Buy
22.08Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 10-Day exponential moving average is 24.96, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-Day exponential moving average is 22.26, making it a Buy.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 50-day simple moving average is 22.89, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 100-day simple moving average is 21.55, creating a Buy signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) 200-day simple moving average is 21.78, creating a Buy signal.

VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD (CURE) Technical Analysis

Aug 21, 2026, 03:21 PM
Name
Value
Action
RSI (14)
83.75
Sell
STOCH (9,6)
109.41
Sell
STOCHRSI (14)
107.24
Sell
MACD (12,26)
0.91
Sell
ADX (14)
24.94
Neutral
Williams %R
-4.56
Sell
CCI (14)
233.31
Sell
ATR (14)
0.34
-
Ultimate Oscillator
108.51
Buy
ROC
22.09
Buy
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Relative Strength Index (RSI) is 83.75, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Trend Strength Indicator (ADX) is 24.94, creating a Neutral signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Commodity Channel Index (CCI) is 233.31, creating a Sell signal.
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD’s (CURE) Price Rate of Change (ROC) is 22.09, creating a Buy signal.

FAQ

Is CURE a Buy, Hold, or Sell?
Based on CURE’s technical indicators, CURE is a Buy.
    What is CURE’s RSI (14)?
    CURE’s RSI (14) is 83.75, which suggests CURE is a Sell.
      What is CURE’s MACD?
      CURE’s MACD is 0.91, which suggests CURE is a Sell.
        What is CURE’s 5-day moving average?
        CURE’s 5-day moving average is 25.35, which suggests CURE is a Buy.
          What is CURE’s 20-day moving average?
          CURE 20-day moving average is 23.64, which suggests CURE is a Buy.
            What is CURE’s 50-day moving average?
            CURE’s 50-day moving average is 22.89, which suggests CURE is a Buy.
              What is CURE’s 200-day moving average?
              CURE’s 200-day moving average is 21.78, which suggests CURE is a Buy.
                What is CURE’s Williams % R (14)?
                CURE’s Williams % R (14) is -4.56, which suggests CURE is a Sell.
                  What is CURE’s CCI (14)?
                  CURE’s CCI (14) is 233.31, which suggests CURE is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis
                    Advertisement